Sermorelin Chemical contact details
A wrong compound name can change an entire account of a result. A precise correction is welcome.
Identifying a possible error
A useful correction would pinpoint the page and sentence, then identify the publication supporting the change. The compound used, the study population and the outcome measured are especially helpful. A paper title, DOI or link from the reading list is enough to identify the source.
The hardest errors here can be small: leaving [Nle27] out of a name, attaching a tesamorelin result to sermorelin, or confusing the peptide’s half-life with the duration of raised GH. Those particulars deserve a correction even when the larger claim still sounds plausible.
Contact availability
There is currently no working message form or published inbox on this site. This page cannot receive a submission. There is no way for me to receive or answer a message through this page.
Questions involving symptoms, a possible adverse effect or a prescription require a clinician who can assess the person and the actual preparation. The site background and published records can clarify the research discussed here; they cannot provide that assessment.